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Living with brain cancer: From researcher to patient
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Abstract
As an academic researcher, my work-life revolves around testing the efficaciousness of pharmaceutical drugs on the
prevention of cardiac dysfunction, arrhythmias, and sudden cardiac death in animal models of heart disease. I never
thought I would go from someone studying a life-threatening disease to a patient living with one in twenty-four hours. Yet,
that transformation occurred October 8, 2019. I was just appointed to Assistant Professor at Johns Hopkins University
School of Medicine (JHUSOM), yet after sitting for my professional headshot I had a grand mal seizure. I cannot recall
this event, but I bit the tip of my tongue off, dislocated my right shoulder, and underwent violent contractions. I was
rushed to the Emergency Department, thankfully within the same building (JHUSOM). A few scans later, I was told I
had ‘a mass’ in my brain that needed to be removed immediately. Fearing the worst, I followed the advice of my newly
appointed neurosurgeon and scheduled surgery for October 19, 2019. I had no time to process what had and what
was about to happen. What followed was two years of post-surgical recovery during a global pandemic, my own personal
awe in the power of medicine, resurgence of my seizures and tumors, and now – my road to recovery through
chemotherapy and radiation. These two years have taught me so much about the day-to-day difficulties patients with
chronic diseases live with, strategies I use to cope with my new normal, and most importantly, the necessity of caregivers.
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Part I:
The Preamble: Seizures and Brain Surgery
In their 2016 essay, Garau, R. highlighted the prevalence
of rare diseases, frequency of misdiagnosed patients with
rare diseases, and how symptoms are frequently
disregarded or overlooked by providers.1 In The Beacon,
Reid J. made a wonderful point regarding the importance
of conducting research on Orphanet diseases, “While a rare
disease is rare,…the prevalence of a disease is of no consolation to
those afflicted [by it]”.2 I often use this quote to inform my
own work, as I research Arrhythmogenic Cardiomyopathy
(ACM) – a rare disease frequently called Sudden Cardiac
Death in Young Athletes.3
I regularly hear patients with ACM describe their
numerous exams: blood work, echo- and
electrocardiograms (ECGs), magnetic resonance imaging
(MRIs), implantable cardiac defibrillator interrogations,
quality of life (QOL) questionnaires, and even
conversations regarding genetic testing for embryonic
uterine implantation.4 I have always sympathized with
patients with ACM; however, this has turned into empathy
since my own diagnosis.
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The past 18 months I have had a plethora of blood work
done, a few ECGs, QOL conversations, and ≥15 MRIs
since my grand mal seizure, which occurred right after
what should have been a joyous moment: transitioning
from fellow to Assistant Professor at one of the most
prestigious universities in the Nation. I had never had a
predisposition to flashing camera lights, but I am grateful
my seizure occurred at JHUSOM where I received
immediate care. When I awoke in the ER, I had already
bitten the tip of my tongue off, dislocated my right
shoulder, and had a CT and MRI scan. None of which I
remember.
Then I listened to the most terrifying words I had ever
heard, “Dr. Chelko, we found a mass (7.3x4cm) in your
right temporal lobe, and we need to act aggressively.” A
few more MRIs later, I underwent brain surgery October
19th, 2019, to remove an isocitrate dehydrogenase-1
(IDH1) mutant glioma. The diffuse astrocytoma
surrounding my IDH1 glioma was inoperable due to how
expansive it covered my right hemisphere. Let’s compare
apples-to-apples: a golf ball is 4x4cm; thus, my tumors
nearly spanned the size of two golf balls. After successfully
removing ~75% of my IDH1 glioma, I left the hospital
less than a week later.
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My intention writing this is to share some medically
important topics and recommendations for others going
through a similar journey. These recommendations are
meant for all patients, not just those with brain cancer:

to terms with:

1. Self-Advocacy

b.

Patients often know when something is not “right.” I am a
research doctor (PhD) that studies the cause(s) of
arrhythmias. Therefore, I am not a medical doctor (MD)
that can diagnosis, prescribe medicine, and/or treat
patients. However, six months leading up to my grand mal
seizure, I visited my primary care physician. I told my
doctor, “I’m on the verge of passing out sometimes, there
is seriously something wrong with me.”
One month prior to my seizure, I passed out at work
(JHUSOM), yet was discharged with “vasovagal syncope,”
despite symptoms I described to emergency room
physicians that were clearly seizure phenotypes. My
symptoms always presented in the same order: (a) strong
copper taste in my mouth, (b) lightheadedness, where I
needed to sit down and put my back against a wall, (c) and
uncontrollable sweat, yet shivering cold. All these
symptoms subsided within ~30mins. I deemed these
instances, “my spells,” that occurred 2-3x/week,
sometimes waking me in the middle of the night. My
psychiatrist wanted to put me on Prozac assuming I had
an anxiety disorder. I resisted.
To be fair, as a researcher and not a medical doctor, I truly
had no clue of what was wrong with me. Six months after
these spells started, I had my first grand mal seizure. When
you know something is wrong, ask for additional exams,
blood work, scans, or even referrals. I wish I had been
stronger in advocating for myself, by pushing my doctors
to investigate my “spells” further.

2. People First

I discovered my disease was sometimes the only thing
people could see about me. People living with disabilities
are just that, people. Since my surgery, I became the faculty
co-advisor for FSU COM’s Disability Advocacy Series. We
explain to medical and physician assistant students the
concept of “Patient First” care. It is quite simple, for
example, “I am Stephen Chelko living with epilepsy and
brain cancer.” I am not, “the epileptic and cancer patient.”
People living with chronic (or acute) illnesses are normal
people. A diagnosis should not strip anyone of their
humanity and individuality.
3. Quality of life (QOL)
Quality of life is an essential component of patient
recovery. I often say to my spouse, “Let me try first.” One
can make a frail person feel helpless by coddling that
person. I want to resume normalcy. I recovered from my
brain surgery, but I’m still accepting my new normal. Here
are a few aspects of my new normal that I’ve had to come
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a.

Accepting reality: I could not accept my diagnosis was
real, even after my surgery. Oftentimes, I still don’t
accept it.
Resentment and anger: not at anyone or anything, but
I find myself extremely angry and resentful. Of
course, I’m not perfect and sometimes this anger
creeps into the relationships I rely upon the most.

c.

A “No Locked Doors” Policy: this applies at work
and even at home (sadly, even the bathroom) in case I
have a seizure. In short, I’ve lost a sense of privacy
and autonomy. When people offer to help me
accomplish simple tasks, that I am perfectly capable
of doing myself, it genuinely underscores my loss of
normalcy and thus breeds resentment.

d.

Driving: I guess this could be added to the “loss of
privacy” QOL aspect, but I feel it deserves its own
category. I can’t drive in my home state unless I’m
one year seizure-free. This has spilled over into
numerous aspects of my life, such as grabbing a
birthday card for a niece, picking up food at the
market to cook for my spouse, and my everyday work
commute. Unless these things are in walking or biking
distance, I must rely on someone else to drive me.

e.

Medications: I’m on Keppra (1,500mg, 2x/day) and
Vimpat (100mg, 2x/day) for the rest of my life. I have
a lot of fear about missing a dose, so I either have to
plan ahead and bring my medication or miss out on
things I would have normally taken for granted prediagnosis.

f.

Tests (So. Many. Tests.): I have an MRI every 3
months to check on the progression of my brain
cancer. I have a wonderful Neuro Team at Johns
Hopkins Hospital, consisting of my neurologist,
neurosurgeon, a plethora of amazing nurses, and most
recently – my neuro-radiation oncologist. I love my
team. I need my team. But to be honest, they serve as a
constant reminder – that this isn’t going away. I feel
like my life has been uprooted, especially considering
my QOL just had some annoyingly difficult aspects
added to it. When life gives you lemons, you must
squeeze them real hard, while grinding your teeth, and
say, “Not today, Lemonade!”

4. Caregivers

Caregivers are ESSENTIAL, POWERFUL, and your
STRONGEST advocate. Caregiving is not an easy task, so
give them time to decompress and try to understand if
they make a few mistakes. They are holding the world on
their shoulders for you, and they may do things that
frustrate you in the moment, like offering unnecessary and
unwanted help. I find myself randomly reaching for my
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spouse’s hand every few hours just to say, “I love you,”
“thank you,” “what can I do for you…?” etc. Surround
yourself with empathetic and motivational caregivers but
realize that no caregiver is perfect.

me. That evening, my spouse and I called my neurologist
back, although the news was still heartbreaking. With my
husband by my side, we were able to process the news and
we came up with a plan.

Part II:
The Treatment: Chemotherapy and Targeted
Radiation

Well, to say the next ensuing months were awful, would be
an understatement. We flew up to Baltimore to get
another MRI, an MR Spectrometer, a CT scan, and to get
fitted for my radiation mask. I had to wear this
claustrophobic mask for the next 6 weeks during my
treatment, every Monday-Friday. My treatment:

I beat this! Successful removal of ~75% of my glioma, all
quarterly MRIs came back as “unremarkable” (which I
later learned is a phenomenal word to hear), and I had been
seizure-free for over a year (02/2020 – 05/2021). I had
done it; I had beaten the unbeatable!
I was now adamant about regaining control of my life. The
first aspect of this QOL change – getting my driver’s
license re-instated. This was a little more difficult than
expected, but I finally obtained my driver’s license on my
third attempt (12/2021). Sadly, I used my license for about
two months. I had a seizure at work in front of my
employees, students, and colleagues on February 9, 2022,
thereby forfeiting my driver’s license and my
independence. Oddly, my MRI scan came back as
unremarkable in January 2022, so this seizure surely had to
be a fluke. Or so I thought. Then I had another, and
another, and another. I was averaging about two
seizures/week. My Neuro Team reiterated to me that the
frequency of seizures did not equal tumor regrowth. Yet,
they wanted to move my upcoming MRI (May 2022) to as
soon as possible (April 14, 2022).
My neurologist called to tell me the results of my MRI just
two days later, I left work hysterical. Lots of crying,
incoherent mumbling followed by inappropriate shouting,
and throwing whatever objects I could grab nearby.
Remember, I run a research laboratory, so some things I
threw were quite expensive. The results of my scan:
“There is a new 0.8cm peripherally enhancing nodule in
the right subinsular lesion…suggestive of infiltrative
astrocytoma. Findings are concerning for neoplastic
progression.” In essence, my tumors were laying down the
proverbial railroad tracks for an impending expansion of
my IDH1 glioma and astrocytoma.
I couldn’t listen. I told my neurologist, “I can’t talk about
this right now. I need my husband to additionally listen,
I’m too emotional to comprehend any of this.” I could not
see through the tears pouring out of my eyes to even take
notes of what my neurologist was saying. I did not
understand what he meant by chemotherapy and especially
Proton Therapy. Or even what a “T2 flair indicative of
regrowth/invasion” meant. To be honest, I just wanted
my spouse as a second ear, but mainly because I needed
him. I truly needed him to tell me “Everything will be
alright.” Even if he didn’t know or was flat out lying to
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1.

Chemotherapy: Temozolomide (140 mg/day for 6
weeks), an antineoplastic chemotherapy that
specifically targets brain cancers. There are lots of
side-effects to chemotherapy, but I was told this
would be a very mild form of chemotherapy.
Regardless, my neurooncologist wanted me to keep a
record of any nausea/vomiting and lack of eating.
Sadly, I still have four more rounds of chemotherapy
ahead of me (Temozolomide; 300 mg/day).
Thankfully, these rounds are only 5 days long and are
separated by 28 days between each round.

2.

Targeted Radiation: I wonder if anyone has heard the
word “radiation” and not been royally freaked. What
is Targeted Radiation? The Gantry at Sibley Memorial
Hospital in Washington, D.C. is a sophisticated
proton therapy machine that delivers targeted beams
of protons to the precise location where the tumor or
cancer resides at, without effecting surrounding
healthy tissue. The machine is huge, much bigger than
an MRI. Thus, one could speculate these would be
easy treatments considering the numerosity of MRIs
I’ve undergone in the past two years. Well, it wasn’t.
That first day going into The Gantry, especially when
they locked my radiation cap over my head – I cried
hysterically, which is quite difficult given the cap is
skin-tight.

I don’t know why I cried: maybe because of the unknown,
some ridiculous fear of spontaneously combusting, the
proton beam would pass through my right hemisphere and
kill healthy brain tissue in my left hemisphere, not
remembering my name (or worse, my husbands’), the list
goes on and on. With tears streaming down my face, a
nurse stepped behind me, rubbed my shoulders and said,
“Everyone is nervous their first day, but you’ll see – it’ll be
done before you know it.” And it was. It was done in
roughly ~20 mins.
Radiation treatment is every Monday-Friday at 7:15 am. So
far, I’ve felt extreme fatigue following treatments, I was
nauseous once, some throbbing behind my right eye
(where my tumors are located), some dull, but long-lasting
headaches, and hair loss at the site of radiation treatment.
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But I’m trying to figure out if I can utilize this for an
upcoming Halloween costume. Consensus is still out.

Part III:
Final Remarks
As I approach my last week of treatment (July 11-15), I
would like to end on some “does and don’ts” and selfreflections.
(a) First things first, people never know what to say, but
they have good intentions. Don’t let it get in the way of your
recovery. I’ve heard people say things like, “I had a friend
with cancer, sadly they didn’t make it, but…” Please,
please don’t tell this to someone going through cancer. We
just want you to say things like, “geez, this really sucks. I’m
here for you.”
(b) You have caregivers and loved ones who are sitting
beside you. In addition to my spouse, I’m staying with my
close friends in Washington, DC, which is convenient for
treatment. But on top of this, my friends bought thirty
pinwheels and have placed one out each morning I go to
treatment. Their yard is filled with pinwheels, providing a
constant reminder they are here to support me.
This last point deserves its own separate paragraph:
(c) Everything seems so trivial now. Grades and deadlines,
they are indeed important, but don’t sweat the small stuff.
Especially if you’re an overachiever like me, where an “A-”
is like a death nail compared to an “A.” That argument I
had with my sibling seems so un-important now. Holding
onto grudges, to make some worthless point or trying so
hard to not lose an argument, seems so ridiculous now.
Mend fences, even if it’s the first, second or nth attempt.
Anyone you love, tell them that. Often. It is worth it. Trust
me.
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As I approach the end of treatment, I hope my
experiences and suggestions are helpful to those beginning
treatment. Each step in this process has seemed
insurmountable, but with the support of some outstanding
healthcare providers and caregivers, I can finally see the
light at the end of a long tunnel. One of my nurses gave
me some great advice from Mother Teresa, “I know God
will not give me anything I can’t handle. I just wish he
didn’t trust me so much.” There were times I didn’t think I
would make it through treatment, but I am stronger than I
thought. I’m sure you too are stronger than you think.
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